Latest filing published 22 Dec 2021 for 南微医学, €156k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -46.7%Entry CN¥159.13 · Close at T+365 CN¥84.85
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
张博: trading record in brief
张博 (board member) discloses dealings in 南微医学 to SSE / SZSE (CSRC). Over a trading history stretching from 25 May 2021 to 22 December 2021, the count stands at 3 filings.
Market trades split into 1 purchase (€156k) and 2 sales (€4.2M). Taken together, the sales exceed the purchases by €4.1M. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
The newest entry dates from 22 December 2021: an open-market purchase of €156k, in 南微医学. Publication is fast: at least half of the trades appear on SSE / SZSE (CSRC) on the same day. That lag is the time during which only the insider knows about the trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SSE / SZSE (CSRC) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to 张博
Open company profiles for insider transactions, fundamentals and analyst consensus when available.